PLx Pharma

PLx Pharma Inc. is a pharmaceutical company that develops and commercializes non-steroidal anti-inflammatory drugs (NSAIDs) for the prescription and over-the-counter markets in the United States. The company offers PL2200 Aspirin, a molecular complex of aspirin and phosphatidylcholine, and PL1100/1200 Ibuprofen, an oral drug product containing a molecular complex of ibuprofen and phosphatidylcholine. It also provides other NSAID-PC products, including PL4500 Indomethacin IV, a molecular complex composed of indomethacin and phosphatidylcholine used in oral and IV dosage forms for the treatment of PDA, and PL5100 Diclofenac, a molecular complex of diclofenac and phosphatidylcholine, which is an oral anti-inflammatory analgesic medication.